Longitudinal efficacy of Ertugliflozin in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Longitudinal efficacy of Ertugliflozin in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials

Published:2023-11-17 Issue:18 Volume:24 Page:2199-2210
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Khan Parvej¹,Venkatesh Shubhashree²,Parveen Rizwana¹,Mishra Pinki¹,Jain Seema³,Agarwal Nidhi¹

Affiliation:

1. Department for Translational and Clinical Research, School of Chemical and Life Sciences, Jamia Hamdard, New Delhi, India

2. Independent Researcher, New Delhi, India

3. Department of Pharmacology, University College of Medical Sciences and GTB Hospital, New Delhi, India

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2023.2279100

Reference37 articles.

1. Ertugliflozin + metformin as a treatment option for type 2 diabetes

2. Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2020 Executive Summary

3. 9. Pharmacologic approaches to glycemic treatment: standards of medical Care in diabetes-2022;Draznin B;Diabetes Care

4. 6. Glycemic targets: standards of medical Care in diabetes-2022;Draznin B;Diabetes Care

5. Home Resources diabetes L with Acknowledgement FAQs Contact. IDF diabetes atlas | tenth edition [internet]. [cited 2022 Aug 11]. Available from: https://diabetesatlas.org/

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP